SFC
GSK icon

Strategic Financial Concepts’s GSK GSK Stock Holding History

Strategic Financial Concepts’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-334,578
Closed -$45.2K – 427
2024
Q2 		$45.2K Buy
+334,578
New +$14.1M 0.03% 251

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Strategic Financial Concepts's GSK Position: Q3 2024 in Review

Strategic Financial Concepts sold out of GSK (GSK) in Q3 2024, closing a stake of 334,578 shares — an estimated $45.2K sold.

Strategic Financial Concepts first reported a position in GSK in Q2 2024 and held it in 1 quarter. The position peaked at $45.2K in Q2 2024. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

  • Strategic Financial Concepts reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
  • Strategic Financial Concepts sold 334,578 GSK shares in Q3 2024, an estimated $45.2K.
  • Strategic Financial Concepts first reported a position in GSK in Q2 2024 and held it in 1 quarter.
  • Strategic Financial Concepts's GSK position peaked at $45.2K in Q2 2024.
  • 899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Strategic Financial Concepts's 13F filing for Q3 2024, filed 12 Nov 2024.